Delivery Order SPE2DB25D3404-SPE2DB25FUMKB

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,516.41 firm fixed-price delivery order is for the supply of 4,567,299,205 units of the pharmaceutical drug lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,587.26 firm fixed-price delivery order contract is for the supply of 100-count lisdexamfetamine 50 mg capsules. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,489,427 units of the medication Lisdexamfetamine 30mg capsules, valued at $2,972.07. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,355.83 firm fixed-price delivery order is for the supply of 4,567,074,436 units of the medication lisdexamfetamine 40 mg capsule. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $1,614.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,489,424 units of the medication lisdexamfetamine 30 mg capsules in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,247.04 firm fixed-price delivery order is for the supply of 4,567,057,343 units of 20 mg Lisdexamfetamine capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 28, 2025 and was awarded on January 27, 2025. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,774.62, is for the delivery of lisdexamfetamine 10 mg capsules in 100-count packages. The contract has an ultimate completion date of February 11, 2025 and is a firm-fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,686.15 firm fixed-price contract is for the delivery of 4,567,031,162 units of the prescription medication lisdexamfetamine 30 mg capsules. The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. It is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,312.39 firm fixed-price delivery order is for the provision of 100-count packages of the pharmaceutical drug lisdexamfetamine 50 mg capsules. The award has an ultimate completion date of November 14, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,426.88, is for the delivery of 4567342796 lisdexamfetamine 30 mg capsules in 100-count packages. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMKB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,981.05 firm fixed-price delivery order is for the supply of 4,567,525,073 units of the drug Lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of March 11, 2025 and was awarded on March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/9/25, 9:56 AM